Top 10 Medical Stocks To Invest In 2019

It can be hard to find great marijuana dividend stocks.

Medical marijuana was first legalized less than 20 years ago in California, so most cannabis companies haven’t been established long enough to make a profit, let alone pay a portion of their profits to shareholders in the form of dividends.

However, investors looking for marijuana stocks with dividends have another option…

Investing in marijuana “pick-and-shovel” plays that offer hefty dividends.

Pick-and-shovel plays allow you to benefit from an industry’s success without taking on the risk that comes with startups.

It’s like investing in Levi Strauss & Co. during the California Gold Rush of the 1840s and 50s. Levi’s didn’t mine gold, but it supplied the garments for the thousands of men who did.

The company’s slogan back then was even “For Men Who Toil.”

Since then, Levi Strass & Co. has become the largest pants manufacturer in the world.

Marijuana pick-and-shovel plays allow investors to profit from the legal pot industry without the risk of owning stock in a company whose product is still illegal under federal law. And because these stocks pay dividends, investors can reinvest their cash rewards to maximize their future returns.

Top 10 Medical Stocks To Invest In 2019: Integrated Device Technology, Inc.(IDTI)

Advisors’ Opinion:

  • [By Ezra Schwarzbaum]

    Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

    Lumentum Holdings Inc (NASDAQ: LITE)
    Ciena Corporation (NYSE: CIEN)
    Coherent, Inc. (NASDAQ: COHR)
    II-VI, Inc. (NASDAQ: IIVI)
    Inphi Corporation (NYSE: IPHI)
    Skyworks Solutions Inc (NASDAQ: SWKS)
    Integrated Device Technology Inc (NASDAQ: IDTI)
    Qorvo Inc (NASDAQ: QRVO)
    Xilinx, Inc. (NASDAQ: XLNX)
    Broadcom Inc (NASDAQ: AVGO)

    Related Links:

Top 10 Medical Stocks To Invest In 2019: Netease.com Inc.(NTES)

Advisors’ Opinion:

  • [By Harsh Chauhan]

    China’s booming video gaming industry has turned out to be a big moneymaker for NetEase (NASDAQ:NTES) in recent years. From operatingActivision’s popular games such as World of Warcraft and Diablo to building a solid portfolio of self-developed mobile games, NetEase has kept its finger on the pulse of the video gaming market to clock terrificgrowth.

  • [By Lisa Levin]

    Check out these big penny stock gainers and losers

    Losers
    Jounce Therapeutics, Inc. (NASDAQ: JNCE) fell 32.5 percent to $11.92 in pre-market trading. Jounce Therapeutics reported that data from ongoing ICONIC trial of JTX-2011 will be presented at the ASCO.
    Acxiom Corporation (NASDAQ: ACXM) fell 10.7 percent to $24.60 in pre-market trading. Acxiom reported stronger-than-expected results for its fourth quarter, but issued weak FY19 guidance.
    American Public Education, Inc. (NASDAQ: APEI) shares fell 10.7 percent to $35 in pre-market trading.
    Enduro Royalty Trust (NYSE: NDRO) shares fell 8.5 percent to $3.25 in pre-market trading after tumbling 10.76 percent on Wednesday.
    NetEase, Inc. (NASDAQ: NTES) fell 8.3 percent to $244.00 in pre-market trading after reporting Q1 results.
    Aircastle Limited (NYSE: AYR) fell 7.2 percent to $21.30 in pre-market trading after announcing 7.9 million secondary offering of common shares.
    Boxlight Corporation (NASDAQ: BOXL) shares fell 5.6 percent to $9.29 in pre-market trading after rising 2.29percent on Wednesday.
    Brainstorm Cell Therapeutics Inc. (NASDAQ: BCLI) shares fell 5.3 percent to $3.93 in pre-market trading after rising 5.60 percent on Wednesday.
    Cisco Systems, Inc. (NASDAQ: CSCO) fell 4 percent to $43.40 in pre-market trading. Cisco reported better-than-expected results for its third quarter. The company sees fourth quarter earnings in the range of 68 cents-70 cents with sales growth of 4-6 percent.
    Jack in the Box Inc. (NASDAQ: JACK) fell 3.2 percent to $88.45 in pre-market trading after the company reported downbeat results for its second quarter. Comps were down 0.1 percent in the quarter. The company sees third-quarter comps coming in flat to up 1 percent.
    Children's Place, Inc. (

  • [By Lisa Levin]

    NetEase, Inc. (NASDAQ: NTES) is expected to post quarterly earnings at $2.19 per share on revenue of $2.18 billion.

    China Distance Education Holdings Limited (NYSE: DL) is estimated to post earnings for its second quarter.

  • [By Joseph Griffin]

    Here are some of the media headlines that may have effected Accern Sentiment’s analysis:

    Get NetEase alerts:

    Marvel Introduces Their First Official Chinese Superheroes (huffingtonpost.com) NetEase, Inc. (NTES) year to date performance remained at -22.66% (nasdaqfortune.com) Marvel get its first official Chinese superheroes (bbc.co.uk) Why to Follow this Stock? NetEase, Inc. (NTES) (nysestocks.review) Marvel’s first Chinese superheroes are comingand here are their superpowers (quartzy.qz.com)

    A number of research firms recently weighed in on NTES. BidaskClub cut NetEase from a “hold” rating to a “sell” rating in a report on Tuesday, March 27th. Jefferies Group reduced their price target on NetEase from $335.00 to $310.00 and set a “hold” rating for the company in a report on Tuesday, April 10th. CLSA raised NetEase from a “sell” rating to an “underperform” rating in a report on Thursday, February 8th. Zacks Investment Research raised NetEase from a “sell” rating to a “hold” rating in a report on Thursday, March 8th. Finally, JPMorgan Chase began coverage on NetEase in a report on Thursday, April 12th. They issued an “underweight” rating and a $240.00 price target for the company. Five research analysts have rated the stock with a sell rating, four have given a hold rating, eight have given a buy rating and one has assigned a strong buy rating to the company’s stock. NetEase currently has a consensus rating of “Hold” and a consensus price target of $337.47.

Top 10 Medical Stocks To Invest In 2019: Stage Stores, Inc.(SSI)

Advisors’ Opinion:

  • [By WWW.GURUFOCUS.COM]

    For the details of AXAR CAPITAL MANAGEMENT L.P.’s stock buys and sells, go to http://www.gurufocus.com/StockBuy.php?GuruName=AXAR+CAPITAL+MANAGEMENT+L.P.

    These are the top 5 holdings of AXAR CAPITAL MANAGEMENT L.P.Stonemor Partners LP (STON) – 6,650,613 shares, 68.21% of the total portfolio. Shares added by 8.91%Patterson-UTI Energy Inc (PTEN) – 730,000 shares, 21.11% of the total portfolio. Stage Stores Inc (SSI) – 1,750,000 shares, 6.3% of the total portfolio. Shares added by 75.00%Five Star Senior Living Inc (FVE) – 2,039,878 shares, 4.38% of the total portfolio. Added

Top 10 Medical Stocks To Invest In 2019: Internet Initiative Japan Inc.(IIJI)

Advisors’ Opinion:

  • [By Logan Wallace]

    Get a free copy of the Zacks research report on Internet Initiative Japan (IIJI)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Medical Stocks To Invest In 2019: Magyar Bancorp Inc.(MGYR)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Media headlines about Magyar Bancorp (NASDAQ:MGYR) have been trending somewhat positive on Friday, according to Accern. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores closest to one being the most favorable. Magyar Bancorp earned a media sentiment score of 0.16 on Accern’s scale. Accern also assigned media headlines about the bank an impact score of 48.0770691063571 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the immediate future.

Top 10 Medical Stocks To Invest In 2019: S&P GSCI(GD)

Advisors’ Opinion:

  • [By ]

    Cramer and Moreno also looked at General Dynamics (GD) which peaked in early March, before starting a downtrend until Tuesday. Last week, General Dynamics fell to the lower end of its channel, but then it bounced right to the high end, and Wednesday it firmly broke out above the high end of this channel. The stochastic oscillator, which is a powerful momentum indicator is making a bullish crossover, and based on today’s move, Moreno thinks General Dynamics can return to its old highs at $230.

  • [By ]

    In addition to increasing the dividend, Action Alerts PLUS holding Raytheon announced in late March that under the Department of Defense’s DARPA program, it was developing technology that could control swarms of both air-based, and ground-based drone vehicles that might be launched using a “drag and drop” visual interface. My price target: $245.

    General Dynamics (GD)

    This is one firm where we have already seen cash flows and margins improving. GD is also another defense name that increased their dividend in March. Think the Navy gets some love in the 2018 federal budget that earmarked $654 billion for the Pentagon? Me too. Know who runs the Virginia class submarine program? General Dynamics. In fact, the Navy just awarded a $696 million modification to that program for 2019.

  • [By Lisa Levin] Companies Reporting Before The Bell
    Thermo Fisher Scientific Inc. (NYSE: TMO) is projected to report quarterly earnings at $2.4 per share on revenue of $5.63 billion.
    Ford Motor Company (NYSE: F) is expected to report quarterly earnings at $0.41 per share on revenue of $37.16 billion.
    Twitter, Inc. (NYSE: TWTR) is projected to report quarterly earnings at $0.11 per share on revenue of $605.26 million.
    Comcast Corporation (NASDAQ: CMCSA) is expected to report quarterly earnings at $0.59 per share on revenue of $22.75 billion.
    General Dynamics Corporation (NYSE: GD) is estimated to report quarterly earnings at $2.52 per share on revenue of $7.6 billion.
    The Boeing Company (NYSE: BA) is expected to report quarterly earnings at $2.58 per share on revenue of $22.24 billion.
    Anthem, Inc. (NYSE: ANTM) is estimated to report quarterly earnings at $4.91 per share on revenue of $22.52 billion.
    Viacom, Inc. (NASDAQ: VIAB) is projected to report quarterly earnings at $0.79 per share on revenue of $3.04 billion.
    Northrop Grumman Corporation (NYSE: NOC) is estimated to report quarterly earnings at $3.61 per share on revenue of $6.61 billion.
    Rockwell Automation Inc. (NYSE: ROK) is expected to report quarterly earnings at $1.81 per share on revenue of $1.66 billion.
    Wipro Limited (NYSE: WIT) is projected to report quarterly earnings at $0.07 per share on revenue of $2.15 billion.
    The Goodyear Tire & Rubber Company (NASDAQ: GT) is expected to report quarterly earnings at $0.46 per share on revenue of $3.82 billion.
    Owens Corning (NYSE: OC) is projected to report quarterly earnings at $0.97 per share on revenue of $1.62 billion.
    T. Rowe Price Group, Inc. (NASDAQ: TROW) is estimated to report quarterly earnings at $1.71 per share on revenue of $1.29 billion.
    Dr Pepper Snapple Group, Inc. (NYSE: DPS) is expected to report quarterly earnings at $1.04 per share on revenue of $1.57 billion.
    Sirius XM Holdings Inc. (NASDAQ: SI
  • [By Reuben Gregg Brewer]

    Shipbuilding and services specialistHuntington Ingalls (NYSE:HII) was spun off from Northup Grumman in early 2011. General Dynamics (NYSE:GD) is roughly six times larger and offers a far more diversified list of products and services that includes submarines, aircraft, and armored vehicles, among other things. Both, however, provide key products and services to the U.S. military. That’s normally a fairly consistent business driven by large and often very long contracts. With a supportive administration in the White House, it would seem like now is a good time to take a look at this pair of stocks. But which of these two military-industrial companies is a better buy? Using a Benjamin Grahamlens, the answer may not be what you want to hear.

  • [By ]

    Only 10% of the companies on the list had female CEOs at the helm, four of which — Hewlett Packard (HP) , Lockheed Martin (LMT) , General Motors (GM) , and General Dynamics (GD) — grew significant revenue in five years or less. 

  • [By Lee Jackson]

    This company, like other major defense prime contractors, had a very solid year and is also on the Merrill Lynch US 1 list.General Dynamics Corp. (NYSE: GD) is engaged in business aviation, land and expeditionary combat vehicles and systems, armaments, munitions, shipbuilding and marine systems, and information systems and technologies.

Top 10 Medical Stocks To Invest In 2019: Boot(h)

Advisors’ Opinion:

  • [By Motley Fool Staff]

    Hyatt Hotels (NYSE:H) Q1 2018 Earnings Conference CallMay. 3, 2018 11:30 a.m. ET

    Contents:
    Prepared Remarks Questions and Answers Call Participants
    Prepared Remarks:

    Operator

  • [By Shane Hupp]

    Shares of Hyatt (NYSE:H) have received a consensus recommendation of “Buy” from the eighteen analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell recommendation, seven have given a hold recommendation and ten have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $80.42.

Top 10 Medical Stocks To Invest In 2019: Sage Therapeutics, Inc.(SAGE)

Advisors’ Opinion:

  • [By ]

    Cramer was bearish on Geron (GERN) , Mitek Systems (MITK) , AK Steel Holding (AKS) , Sage Therapeutics (SAGE) and AbbVie (ABBV) .

    Search Jim Cramer’s “Mad Money” trading recommendations using our exclusive “Mad Money” Stock Screener.

  • [By Chris Lange]

    Buy-dip on several “Potential Blockbusters” Aimmune Therapeutics, Inc. (NASDAQ: AIMT), Audentes Therapeutics, Inc. (NASDAQ: BOLD), AveXis, Inc. (NASDAQ: AVXS), Bluebird Bio, Inc. (NASDAQ: BLUE), Esperion Therapeutics, Inc. (NASDAQ: ESPR), and Sage Therapeutics, Inc. (NASDAQ: SAGE) are buy-dip candidates given their bullish trends and favorable technical patterns. Intercept Pharmaceuticals, Inc. (NASDAQ: ICPT), Prothena Corp. PLC (NASDAQ: PRTA), Tesaro, Inc. (NASDAQ: TSRO) and Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE) have bearish set-ups. Heron Therapeutics, Inc. (NASDAQ: HRTX) is bigger picture bullish, but may correct further on a move below $19.55. Clovis Oncology, Inc. (NASDAQ: CLVS) has bearish set-up and bulls need to push above $69 to invalidate.

  • [By Dan Caplinger]

    Friday was a poor day on Wall Street, as the Dow Jones Industrials fell 200 points and other major benchmarks lost about 1%. Rising bond yields were a major source of consternation among those following the financial markets, with the 10-year Treasury hitting 2.95% and helping to send mortgage rates sharply higher. Even though earnings season has gone fairly well for many companies, some investors are also starting to realize that political issues are likely to cloud the outlook for the U.S. economy in the coming months, creating more uncertainty that could stymie further market gains. Some bad news affecting individual companies also added to the negative mood. Stanley Black & Decker (NYSE:SWK), ManpowerGroup (NYSE:MAN), and Sage Therapeutics (NASDAQ:SAGE) were among the worst performers on the day. Here’s why they did so poorly.

  • [By ]

    Sage Therapeutics (SAGE) : “Let’s wait and see. I can’t bless it until I see more from them.”

    AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”

Top 10 Medical Stocks To Invest In 2019: P.T. Telekomunikasi Indonesia Tbk.(TLK)

Advisors’ Opinion:

  • [By Max Byerly]

    Telekomnks Indn Prsr Tbk Prshn Prsrn (NYSE:TLK) was upgraded by equities research analysts at Macquarie from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Wednesday, The Fly reports.

  • [By Lisa Levin]

    Tuesday afternoon, the telecommunication services shares climbed 1.18 percent. Meanwhile, top gainers in the sector included Intelsat S.A. (NYSE: I), up 7 percent, and Telekomnks Indn Prsr Tbk Prshn Prsrn-ADR (NYSE: TLK), up 3 percent.

Top 10 Medical Stocks To Invest In 2019: Covenant Transportation Group, Inc.(CVTI)

Advisors’ Opinion:

  • [By Shane Hupp]

    ValuEngine upgraded shares of Covenant Transport (NASDAQ:CVTI) from a buy rating to a strong-buy rating in a research report sent to investors on Saturday morning.

  • [By Shane Hupp]

    Old Dominion Freight Line (NASDAQ: ODFL) and Covenant Transport (NASDAQ:CVTI) are both transportation companies, but which is the better stock? We will compare the two businesses based on the strength of their analyst recommendations, profitability, earnings, dividends, valuation, risk and institutional ownership.